Amlodipine And Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 65862-855

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amlodipine And Olmesartan Medoxomil (NDC 65862-855). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figures 1 & 2 (Amlodipineolme Fig1)

Figures 1 & 2 (Amlodipineolme Fig1)
This text describes a clinical study of medications used to regulate blood pressure. It includes data and figures related to the probability of achieving systolic blood pressure (SBP) and diastolic blood pressure (DBP) levels. The medications studied include Olmesartan Medoxomil and Amlodipine. There are also tables of numerical data related to blood pressure readings.*
FDA Label Image

Figures 3 & 4 (Amlodipineolme Fig2)

FDA Label Image

Package Label-principal Display Panel (5 mg/20 mg (30 Tablet Bottle))

Package Label-principal Display Panel (5 mg/20 mg (30 Tablet Bottle))
This is a medication with National Drug Code 65862-854-30 containing 6.95 mg of amlodipine and 20mg of olmesartan medoxomil per film-coated tablet. The tablets are made in India by Aurobindo Pharma USA, Inc. The package insert should be consulted for dosage and usage instructions. The tablets should be stored at 20° to 25°C and excursions between 15° to 30°C are permitted. There is an over printing zone and a coding area on the package.*
FDA Label Image

Package Label-principal Display Panel (5 mg/40 mg (30 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (10 mg/20 mg (30 Tablet Bottle))

Package Label-principal Display Panel (10 mg/20 mg (30 Tablet Bottle))
The text describes a prescription-only medication called Amlodipine and Olmesartan Medoxomil, containing 10 mg of amlodipine besylate and 20 mg of olmesartan medoxomil. It is manufactured by Aurobindo Pharma USA, Inc. and is distributed in the form of 30 film-coated tablets. The package insert contains information about dosage and use. The medication should be stored at a temperature between 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The code on the package is TS/DRUGS/22/2009.*
FDA Label Image

Package Label-principal Display Panel (10 mg/40 mg (30 Tablet Bottle))

Package Label-principal Display Panel (10 mg/40 mg (30 Tablet Bottle))
This is a description of Amlodipine and Olmesartan Medoxomil Tablets, USP manufactured by Aurobindo Pharma USA. It contains 13.90 mg of amlodipine besylate, USP, equivalent to amlodipine 10 mg and olmesartan medoxomil USP 40 mg. The tablets come in a bottle of 30 and are for Rx only. Dosage and use information can be found in the package insert. The store temperature should be 20° to 25°C (68° to 77°F) with excursions allowed up to 15° to 30°C (59° to 86°F). The distribution center is located in East Windsor, NJ.*
FDA Label Image

Amlodipine Chemical Structure (Amlodipineolme Str1)

FDA Label Image

Olmesartan Chemical Structure (Amlodipineolme Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.